Status:
UNKNOWN
Evaluation of Neuroinflamation of SAH
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Subarachnoid Hemorrhage, Aneurysmal
Eligibility:
All Genders
Brief Summary
The investigators are planning that can these markers be used a predictive marker at SAH and for this aim we will study both patiens' blood sample and their CT image.
Detailed Description
An ideal marker which could be used clinically should meet numerous criteria, such as high sensitivity or the possibility of easy and quick assessment of its concentration in blood or blood plasma.The...
Eligibility Criteria
Inclusion
- Ruptured Subarachnoid Aneursym
Exclusion
- without aneursymal sah
- Patient's positive for rheumatoid factor and anti-CCP or with chronic inflammatory diseases (such as ankylosing spondylitis or rheumatoid arthritis), systemic diseases (such as hypercholesterolemia, hypertension, diabetes mellitus, myocardial infarction, stroke, peripheral artery disease), active infection, a history of term medication, trauma to the hip and smoking were excluded from the study.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03822260
Start Date
January 1 2017
End Date
June 1 2019
Last Update
January 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.